pilsicainide has been researched along with Genetic Predisposition in 1 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ogawa, R | 1 |
Kishi, R | 1 |
Takagi, A | 1 |
Sakaue, I | 1 |
Takahashi, H | 1 |
Matsumoto, N | 1 |
Masuhara, K | 1 |
Nakazawa, K | 1 |
Kobayashi, S | 1 |
Miyake, F | 1 |
Echizen, H | 1 |
1 other study available for pilsicainide and Genetic Predisposition
Article | Year |
---|---|
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese.
Topics: Adult; Age Factors; Aged; Asian People; Brugada Syndrome; Electrocardiography; Female; Genetic Predi | 2010 |